Compared to IGF-1 LR3, growth hormone therapy has been studied much more extensively, and a considerable amount of evidence supports its effectiveness in increasing lean muscle mass and improving quality of life
doi: 10.1073/pnas.0605296103 117 CampbellDBDOronzioRGarbettKEbertPJMirnicsKLevittPet al
PMCID: PMC3407788
showed that 4-week liraglutide administration in a SD rat NAFLD model reduced body weight, food intake, and LFTs, leading to improvement in insulin resistance, hepatic steatosis, lobular inflammation, and hepatocellular ballooning
Numerous studies have confirmed that DM independently increases the risk of conditions such as ischemic stroke, transient ischemia, and vascular dementia (Sarwar et al., 2010
BPC-157 / TB-500 Blend 10mg The BPC-157 and TB-500 blend combines two of the most researched regenerative peptides into a single, convenient vial